Nigerooligosaccharides augments mitogen-induced proliferation and suppresses activation-induced apoptosis of human peripheral blood mononuclear cells

Immunopharmacology and Immunotoxicology

Volumn 26, Issue 3, 2004, Pages 387-399

  Hirose, Yoshitaka ^a   Murosaki, Shinji ^a   Yamamoto, Yoshihiro ^a   Ikematsu, Hideyuki ^b   Nomoto, Kikuo ^c  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b Hara Doi Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Metabolic demand; Nigerooligosaccharides; Peripheral blood mononuclear cells; Proliferation

Indexed keywords

BROXURIDINE; CARBOHYDRATE DERIVATIVE; CONCANAVALIN A; GLUCOSE; IMMUNOSTIMULATING AGENT; NIGEROOLIGOSACCHARIDE; NIGEROSE; NIGEROSYLMALTOOLIGOSACCHARIDE; OLIGOSACCHARIDE; PICIBANIL; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL PROLIFERATION; CELL VIABILITY; CLINICAL TRIAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG POTENTIATION; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE ACTIVATION; MALE; METABOLISM; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGING; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; DISACCHARIDES; DRUG COMBINATIONS; GLUCOSE; HUMANS; INTESTINAL ABSORPTION; MALE; MONOCYTES; OLIGOSACCHARIDES; PICIBANIL; RANDOMIZED CONTROLLED TRIALS;

EID: 5044237153     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-200026885     Document Type: Article

References (23)

1. Konishi, Y.; Shindo, K. Production of nigerose, nigerosyl glucose, and nigerosyl maltose by Acremonium sp. S4G13. Biosci. Biotech. Biochem. 1997, 61 (3), 439-442.
2. Murosaki, S.; Muroyama, K.; Yamamoto, Y.; Kusaka, H.; Liu, T.; Yoshikai, Y. Immunopotentiating activity of nigerooligosaccharides for T helper 1-like immune response in mice. Biosci. Biotech. Biochem. 1999, 63 (2), 373-378.
3. Murosaki, S.; Ikematsu, H.; Yamamoto, Y.; Yukami, S.; Nomoto, K. Effects of intake of nigerooligosaccharides-supplemented syrup on the immune function and Quality of Life in the healthy elderly. Jpn. Pharmacol. Ther. 2001, 29 (11), 815-826.
4. Murosaki, S.; Ikematsu, H.; Hirose, Y.; Yamamoto, Y.; Yukami, S.; Nomoto, K. Effects of intake of nigerooligosaccharides-supplemented syrup on the immune function and Quality of Life in the healthy young adult subjects. Jpn. Pharmacol. Ther. 2002, 30 (2), 81-90.
5. Field, C.J. Use of T cell function to determine the effect of physiologically active food components. Am. J. Clin. Nutr. 2000, 71 (Suppl. 9), 1720-1727.
6. Pawelec, G.; Adibzadeh, M.; Pohla, H.; Schaudt, K. Immunosenescence: aging of the immune system. Immunol. Today 1995, 16 (9), 420-422.
7. Grubeck-Loebenstein, B.; Wick, G. The aging of the immune system. Adv. Immunol. 2002, 80, 243-284.
8. Hemdon, F.J.; Hsu, H.C.; Mountz, J.D. Increased apoptosis of CD45RO- T cells with aging. Mech. Ageing Dev. 1997, 94 (1-3), 123-134.
9. Schindowski, K.; Leutner, S.; Muller, W.E.; Eckert, A. Age-related changes of apoptotic cell death in human lymphocytes. Neurobio. Ageing 2000, 21 (5), 661-670.
10. Yasuno, S.; Kokubo, K.; Kamei, M. New method for determining the sugar composition of glycoproteins, glycolipids, and oligosaccharides by high-performance liquid chromatography. Biosci. Biotech. Biochem. 1999, 63 (8), 1353-1359.
11. Yamamoto, T.; Unno, T.; Sugawara, M.; Goda, T. Properties of nigerose and nigerosylmaltooligosaccharides-supplemented syrup. J. Appl. Glycosci. 1999, 46 (4), 475-482.
12. Pike, M.G.; Heddle, R.J.; Boulton, P.; Tuner, M.W.; Atherton, D.J. Increased intestinal permeability in atopic eczema. J. Investig. Dermatol. 1986, 86 (2), 101-104.
13. De Cock, W.; De Cree, J.; Van Wauwe, J.; Verhaegen, H. Measurement of mitogen stimulation of lymphocytes with a glucose consumption test. J. Immunol. Methods 1980, 33 (2), 127-131.
14. Mosmann, T. Rapid calorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65 (1-2), 55-63.
15. Takamatsu, N. The new calorimetric assay (WST-1) for cellular growth with normal aging and Alzheimer's disease. Jpn. J. Geriatrics 1998, 35 (7), 535-542.
16. Krauss, S.; Brand, M.D.; Buttgereit, F. Signaling takes a breath-new quantitative perspectives on bioenergetics and signal transduction. Immunity 2001, 15 (4), 497-502.
17. Patarca, R. Cytokines and chronic fatigue syndrome. Ann. N.Y. Acad. Sci. 2001, 933, 185-200.
18. Hassan, I.S.; Bannister, B.A.; Akbar, A.; Weir, W.; Botill, M. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin. Immunol. Immunopathol. 1998, 87 (1), 60-67.
19. Schulze-Osthoff, K.; Ferrari, D.; Los, M.; Wesselborg, S.; Peter, M.E. Apoptosis signaling by death receptors. Eur. J. Biochem. 1998, 254 (3), 439-459.
20. Dhein, J.; Walczak, H.; Baumler, C.; Debatin, K.M.; Krammer, P.H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995, 373 (6513), 438-441.
21. Brunner, T.; Mogil, R.J.; LaFace, D.; Yoo, N.J.; Mahboubi, A.; Echeverri, F.; Martin, S.J.; Force, W.R.; Lynch, D.H.; Ware, C.F.; Douglas, R.G. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995, 373 (6513), 441-444.
22. Ju, S.T.; Panka, D.J.; Cui, H.; Ettinger, R.; el-Khatib, M.; Sherr, D.H.; Stanger, B.Z.; Marshak-Rothstein, A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995, 373 (6513), 444-448.
23. Pahlavani, M.A.; Vargas, D.A. Activation-induced apoptosis in T cells from young and old Fischer 344 rats. Int. Arch. Allergy Immunol. 2000, 122 (3), 182-189.